EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
5.3.99.4 | 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | - |
Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.3.99.4 | Sus scrofa | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
5.3.99.4 | partial | Sus scrofa |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
5.3.99.4 | artery | vascular | Sus scrofa | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
5.3.99.4 | additional information | - |
assay methods | Sus scrofa |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.4 | prostaglandin G2 | - |
Sus scrofa | prostaglandin I2 + 15-hydroperoxyprostacyclin | 15-hydroperoxyprostacyclin decomposes to 6,15-diketo-prostaglandin F1alpha | ? | |
5.3.99.4 | Prostaglandin H2 | - |
Sus scrofa | Prostaglandin I2 | prostaglandin I2 | ? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
5.3.99.4 | 6.8 | 7.5 | - |
Sus scrofa |